EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 104 filers reported holding EPIZYME INC in Q1 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $188,000 | -20.7% | 14,989 | -61.0% | 0.04% | -34.0% |
| Q4 2018 | $237,000 | +52.9% | 38,402 | +161.9% | 0.05% | +82.8% |
| Q3 2018 | $155,000 | -71.0% | 14,661 | -38.8% | 0.03% | -75.6% |
| Q2 2015 | $535,000 | +6.4% | 23,960 | -6.8% | 0.12% | -13.1% |
| Q1 2015 | $503,000 | – | 25,712 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |